Cancer Therapy

Liver cancer expert presents new data on SIR-Spheres

Published in Hepatitis Weekly, June 28th, 2004

A leading expert in the treatment of liver cancer presented new data on SIR-Spheres at the World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA).

Dr. Richard Stubbs of the Wakefield Gastroenterology Centre in Wellington, New Zealand, presented evidence that treatment with SIR-Spheres (C2616-Brachytherapy-Yttrium 90) - a form of therapeutic radioactive implant used to treat liver cancer - can reduce liver tumors in more than 90% of patients after a single treatment of SIR-Spheres.

"Secondary" liver cancer refers to cancer that has spread to the liver from other locations, often the large bowel and areas affected by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2004-06-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry